These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
113 related items for PubMed ID: 15637470
1. Structural and functional modification of THP on nitration: comparison with stone formers THP. Pragasam V, Kalaiselvi P, Subashini B, Sumitra K, Varalakshmi P. Nephron Physiol; 2005; 99(1):p28-34. PubMed ID: 15637470 [Abstract] [Full Text] [Related]
2. Immunological detection of nitrosative stress-mediated modified Tamm-Horsfall glycoprotein (THP) in calcium oxalate stone formers. Pragasam V, Kalaiselvi P, Sumitra K, Srinivasan S, Anandkumar P, Varalakshmi P. Biomarkers; 2006; 11(2):153-63. PubMed ID: 16766391 [Abstract] [Full Text] [Related]
3. Tamm-Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function. Jaggi M, Nakagawa Y, Zipperle L, Hess B. Urol Res; 2007 Apr; 35(2):55-62. PubMed ID: 17345077 [Abstract] [Full Text] [Related]
4. Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls. Borghi L, Meschi T, Guerra A, Bergamaschi E, Mutti A, Novarini A. Clin Chim Acta; 1995 Jul 31; 239(1):1-11. PubMed ID: 7586581 [Abstract] [Full Text] [Related]
5. Isoelectric focusing of native urinary uromodulin (Tamm-Horsfall protein) shows no physicochemical differences between stone formers and non-stone formers. Trewick AL, Rumsby G. Urol Res; 1999 Aug 31; 27(4):250-4. PubMed ID: 10460894 [Abstract] [Full Text] [Related]
6. Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers. Borghi L, Guerra A, Meschi T, Briganti A, Schianchi T, Allegri F, Novarini A. Kidney Int; 1999 Mar 31; 55(3):1041-50. PubMed ID: 10027942 [Abstract] [Full Text] [Related]
7. Tamm-Horsfall protein excretion and its relation to citrate in urine of stone-forming patients. Ganter K, Bongartz D, Hesse A. Urology; 1999 Mar 31; 53(3):492-5. PubMed ID: 10096372 [Abstract] [Full Text] [Related]
8. Beneficial effect of vitamin E supplementation on the biochemical and kinetic properties of Tamm-Horsfall glycoprotein in hypertensive and hyperoxaluric patients. Sumitra K, Pragasam V, Sakthivel R, Kalaiselvi P, Varalakshmi P. Nephrol Dial Transplant; 2005 Jul 31; 20(7):1407-15. PubMed ID: 15855216 [Abstract] [Full Text] [Related]
9. Citrate determines calcium oxalate crystallization kinetics and crystal morphology-studies in the presence of Tamm-Horsfall protein of a healthy subject and a severely recurrent calcium stone former. Hess B, Jordi S, Zipperle L, Ettinger E, Giovanoli R. Nephrol Dial Transplant; 2000 Mar 31; 15(3):366-74. PubMed ID: 10692522 [Abstract] [Full Text] [Related]
10. Crystalline aggregation in vitro: interaction between urinary macromolecules and the micromolecular environment. Guerra A, Meschi T, Schianchi T, Allegri F, Novarini A, Borghi L. Acta Biomed; 2002 Mar 31; 73(1-2):11-26. PubMed ID: 12233273 [Abstract] [Full Text] [Related]
11. Urinary macromolecular inhibition of crystal adhesion to renal epithelial cells is impaired in male stone formers. Kumar V, Peña de la Vega L, Farell G, Lieske JC. Kidney Int; 2005 Oct 31; 68(4):1784-92. PubMed ID: 16164655 [Abstract] [Full Text] [Related]
12. Comparison of fibronectin content in urinary macromolecules between normal subjects and recurrent stone formers. Tsujihata M, Miyake O, Yoshimura K, Kakimoto K, Takahara S, Okuyama A. Eur Urol; 2001 Oct 31; 40(4):458-62. PubMed ID: 11713403 [Abstract] [Full Text] [Related]
13. The relation of urinary Tamm-Horsfall-protein on CaOx-crystallization under the scope of the Bonn-Risk-Index. Laube N, Glatz S, Hesse A. Urol Res; 2001 Feb 31; 29(1):45-9. PubMed ID: 11310215 [Abstract] [Full Text] [Related]
14. Effects of Tamm-Horsfall protein on the protection of MCDK cells from oxalate induced free radical injury. Hsieh N, Shih CH, Chen HY, Wu MC, Chen WC, Li CW. Urol Res; 2003 Mar 31; 31(1):10-6. PubMed ID: 12624657 [Abstract] [Full Text] [Related]
15. Tamm-Horsfall glycoprotein--inhibitor or promoter of calcium oxalate monohydrate crystallization processes? Hess B. Urol Res; 1992 Mar 31; 20(1):83-6. PubMed ID: 1736492 [Abstract] [Full Text] [Related]
16. Isoelectric focusing of Tamm-Horsfall glycoproteins: a simple tool for recognizing recurrent calcium oxalate renal stone formers. Schnierle P, Hering F, Seiler H. Urol Res; 1996 Mar 31; 24(2):79-82. PubMed ID: 8740976 [Abstract] [Full Text] [Related]
17. Decreased Tamm-Horsfall protein in lithiasic patients. Romero MC, Nocera S, Nesse AB. Clin Biochem; 1997 Feb 31; 30(1):63-7. PubMed ID: 9056112 [Abstract] [Full Text] [Related]
18. Patients with recurrent renal stones have a physico-chemically altered urinary Tamm-Horsfall glycoprotein profile. Jefferson A, Reynolds TM, Elves A, Wierzbicki AS. Ann Clin Biochem; 1996 Nov 31; 33 ( Pt 6)():540-4. PubMed ID: 8937586 [Abstract] [Full Text] [Related]
19. [Sialic acid determinations of serum and urine specimens in calcium-containing urinary stone formers]. Konya E, Umekawa T, Kurita T, Iguchi M, Kataoka K. Nihon Hinyokika Gakkai Zasshi; 1997 Nov 31; 88(11):917-22. PubMed ID: 9423304 [Abstract] [Full Text] [Related]
20. Comparison of urinary proteins in calcium stone formers and healthy individuals: a case-control study. Pourmand G, Nasseh H, Sarrafnejad A, Mojtahedi A, Mehrsai A, Alamdari DH, Nourijelyani K. Urol Int; 2006 Nov 31; 76(2):163-8. PubMed ID: 16493220 [Abstract] [Full Text] [Related] Page: [Next] [New Search]